Viewing StudyNCT00481559



Ignite Creation Date: 2024-05-05 @ 5:33 PM
Last Modification Date: 2024-10-26 @ 9:33 AM
Study NCT ID: NCT00481559
Status: APPROVED_FOR_MARKETING
Last Update Posted: 2014-01-17
First Post: 2007-05-30

Brief Title: Treatment Protocol of Voraxaze for Patients Experiencing or at Risk of Methotrexate Toxicity
Sponsor: BTG International Inc
Organization: BTG International Inc

Conditions & Keywords Data

Conditions:
Name
Neoplasms
Keywords:
Name View
Voraxaze View
glucarpidase View
carboxypeptidase View
cancer View
lymphoma View
leukemia View
osteosarcoma View
methotrexate View
delayed elimination View
renal insufficiency View
toxicity View